Mark Hamner to Attention Deficit Disorder with Hyperactivity
This is a "connection" page, showing publications Mark Hamner has written about Attention Deficit Disorder with Hyperactivity.
Connection Strength
0.787
-
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
Score: 0.666
-
Cue-dependent inhibition in posttraumatic stress disorder and attention-deficit/hyperactivity disorder. J Anxiety Disord. 2017 Oct; 51:1-6.
Score: 0.121